ALK-Abello A/S operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Christian Hansen Holding with three other
pharmaceutical manufacturers in Europe:
Nuevolution AB (publ)
sales of 120.32 million Swedish Kronor [US$14.86 million]
ExpreS2ion Biotech Holding AB
(9.80 million Swedish Kronor [US$1.21 million]
based in the United Kingdom
(£3.13 million [US$4.38 million]
of which 38%
Christian Hansen Holding reported sales of 2.91 billion Danish Kroner (US$482.10 million)
December of 2017.
decrease of 3.2%
versus 2016, when the company's sales were 3.01 billion Danish Kroner.
Contributing to the drop in overall sales was the 12.5% decline
in Scit/slit Drops, from 2.19 billion Danish Kroner to 1.92 billion Danish Kroner.
However, these declines were partially offset by the increase in sales of
Slit - Tablets (up 6.9% to 528.00 million Danish Kroner)
Other Products and Services (up 44.9% to 465.00 million Danish Kroner)